The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) advised Thursday that people in the UK should continue getting their COVID-19 vaccines, including the shot developed by Oxford and AstraZeneca, after Denmark and other countries restricted their use of it, as reported in London South East.
Danish authorities said the country is suspending the use of AstraZeneca's vaccine for two weeks after reports of the formation of blood clots in some who have received the vaccine, including one death in Denmark.
Norway also halted the vaccine's roll-out after reports of blood clots, while Italy banned a batch of the vaccine after it was notified of some serious adverse effects.
The MHRA said it had not been confirmed that the reported blood clot in Denmark was caused by the vaccine, adding that the Danish suspension was precautionary.
"Blood clots can occur naturally and are not uncommon," said Phil Bryan, MHRA vaccines safety lead. "We are keeping this issue under close review but available evidence does not confirm that the vaccine is the cause. People should still go and get their COVID-19 vaccine when asked to do so."
Earlier this week, Austria halted a batch of the vaccine, however the European Medicines Agency said on Wednesday there was no evidence so far linking AstraZeneca's vaccine to illnesses in two people who received it.
To read more NewsPoints articles, click here.